Targeting signal transduction as a strategy to treat inflammatory diseases
LAJ O'Neill - Nature reviews Drug discovery, 2006 - nature.com
Inflammatory diseases are a major burden on humanity, despite recent successes with
biopharmaceuticals. Lack of responsiveness and resistance to these drugs, delivery …
biopharmaceuticals. Lack of responsiveness and resistance to these drugs, delivery …
New approaches to the treatment of inflammatory disease: focus on small-molecule inhibitors of signal transduction pathways
YA Ivanenkov, KV Balakin, SE Tkachenko - Drugs in R & D, 2008 - Springer
Abstract This 'state-of-the-art'review specifically focuses on alternative signalling pathways
deeply involved in acute and chronic inflammatory responses initiated by various …
deeply involved in acute and chronic inflammatory responses initiated by various …
Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation?
E Andreakos, B Foxwell, M Feldmann - Immunological reviews, 2004 - Wiley Online Library
Cytokine‐driven inflammation and tissue destruction is a common theme of chronic
inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis …
inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis …
New targets for anti-inflammatory drugs
AJ Lewis, AM Manning - Current opinion in chemical biology, 1999 - Elsevier
Inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel
diseases, multiple sclerosis, psoriasis and asthma, provide drug discoverers with a …
diseases, multiple sclerosis, psoriasis and asthma, provide drug discoverers with a …
Targeting innate immunity protein kinase signalling in inflammation
Inflammation is an evolutionarily conserved host reaction that is initiated in response to
trauma, tissue damage and infection. It leads to changes in tissue homeostasis and blood …
trauma, tissue damage and infection. It leads to changes in tissue homeostasis and blood …
Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy
SW Tas, PHJ Remans, KA Reedquist… - Current pharmaceutical …, 2005 - ingentaconnect.com
Many chronic inflammatory diseases are associated with deregulated intracellular signal
transduction pathways. Resultant pathogenic interactions between immune and stromal …
transduction pathways. Resultant pathogenic interactions between immune and stromal …
NF-κB signaling and inflammation—Drug repurposing to treat inflammatory disorders?
A Roberti, LE Chaffey, DR Greaves - Biology, 2022 - mdpi.com
Simple Summary Since its first description 35 years ago, the transcription factor NF-κB
(nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key …
(nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key …
Strategies to therapeutically modulate cytokine action
WJ Leonard, JX Lin - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted or membrane-presented molecules that mediate broad cellular
functions, including development, differentiation, growth and survival. Accordingly, the …
functions, including development, differentiation, growth and survival. Accordingly, the …
[PDF][PDF] Pro-inflammatory signaling: last pieces in the NF-κB puzzle?
PA Baeuerle - Current Biology, 1998 - cell.com
Pro-inflammatory signaling: Last pieces in the NF-kB puzzle? Page 1 Dispatch R19 Pro-inflammatory
signaling: Last pieces in the NF-kB puzzle? Patrick A. Baeuerle The discovery of three …
signaling: Last pieces in the NF-kB puzzle? Patrick A. Baeuerle The discovery of three …
Negative regulatory approaches to the attenuation of Toll-like receptor signaling
Toll-like receptors (TLRs) are pivotal components of the innate immune response, which is
responsible for eradicating invading microorganisms through the induction of inflammatory …
responsible for eradicating invading microorganisms through the induction of inflammatory …